Human chorionic gonadotropin (hCG) has become more widely used in post-cycle therapy (PCT) because it directly stimulates Leydig cells in the testes. This helps restore testosterone production while the hypothalamic–pituitary–testicular axis (HPTA) is still suppressed after a steroid cycle.